162 related articles for article (PubMed ID: 14986883)
1. The cardiotonic effects of levosimendan in guinea pig hearts are modulated by beta-adrenergic stimulation.
Bódi A; Szilágyi S; Edes I; Papp Z
Gen Physiol Biophys; 2003 Sep; 22(3):313-27. PubMed ID: 14986883
[TBL] [Abstract][Full Text] [Related]
2. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
[TBL] [Abstract][Full Text] [Related]
3. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
5. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
6. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
Haikala H; Kaheinen P; Levijoki J; Lindén IB
Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
[TBL] [Abstract][Full Text] [Related]
7. The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts.
Kristof E; Szigeti G; Papp Z; Bodi A; Ball NA; Walsh RA; Edes I
Basic Res Cardiol; 1999 Aug; 94(4):223-30. PubMed ID: 10505421
[TBL] [Abstract][Full Text] [Related]
8. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
9. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
Nagy L; Pollesello P; Haikala H; Végh Á; Sorsa T; Levijoki J; Szilágyi S; Édes I; Tóth A; Papp Z; Papp JG
Eur J Pharmacol; 2016 Mar; 775():120-9. PubMed ID: 26872993
[TBL] [Abstract][Full Text] [Related]
10. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
[TBL] [Abstract][Full Text] [Related]
11. The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig.
Szilágyi S; Pollesello P; Levijoki J; Kaheinen P; Haikala H; Edes I; Papp Z
Eur J Pharmacol; 2004 Feb; 486(1):67-74. PubMed ID: 14751410
[TBL] [Abstract][Full Text] [Related]
12. The effects of levosimendan on [Ca2+]i in guinea-pig isolated ventricular myocytes.
Lancaster MK; Cook SJ
Eur J Pharmacol; 1997 Nov; 339(1):97-100. PubMed ID: 9450621
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the contractile effects of levosimendan in the mammalian heart.
Bokník P; Neumann J; Kaspareit G; Schmitz W; Scholz H; Vahlensieck U; Zimmermann N
J Pharmacol Exp Ther; 1997 Jan; 280(1):277-83. PubMed ID: 8996207
[TBL] [Abstract][Full Text] [Related]
14. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
[TBL] [Abstract][Full Text] [Related]
15. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
Kaheinen P; Pollesello P; Levijoki J; Haikala H
J Cardiovasc Pharmacol; 2004 Apr; 43(4):555-61. PubMed ID: 15085067
[TBL] [Abstract][Full Text] [Related]
16. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
17. Ischemia-reperfusion injury changes the dynamics of Ca2+-contraction coupling due to inotropic drugs in isolated hearts.
Rhodes SS; Ropella KM; Camara AK; Chen Q; Riess ML; Pagel PS; Stowe DF
J Appl Physiol (1985); 2006 Mar; 100(3):940-50. PubMed ID: 16282437
[TBL] [Abstract][Full Text] [Related]
18. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
19. Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic inotropic response of the myocardium.
Lochner A; Colesky F; Genade S
Cardiovasc Drugs Ther; 2000 Jun; 14(3):271-81. PubMed ID: 10935149
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium.
Brixius K; Reicke S; Schwinger RH
Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H131-7. PubMed ID: 11748056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
